tocophersolan has been researched along with celecoxib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mosquera-Giraldo, LI; Taylor, LS; Trasi, NS | 1 |
| Baek, IH; Cho, W; Choo, GH; Ha, ES; Hwang, SJ; Jeong, HY; Jung, YS; Kim, JS; Kim, MS; Noh, J; Ok, J | 1 |
| Subongkot, T | 1 |
| He, K; Jiang, M; Li, J; Liu, Q; Qiu, T; Sun, J; Yang, M; Zhan, S; Zhang, X | 1 |
4 other study(ies) available for tocophersolan and celecoxib
| Article | Year |
|---|---|
Impact of surfactants on the crystal growth of amorphous celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Celecoxib; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Drug Stability; Polyethylene Glycols; Polymers; Povidone; Pyrazoles; Sodium Dodecyl Sulfate; Solubility; Sucrose; Sulfonamides; Surface-Active Agents; Temperature; Vitamin E; X-Ray Diffraction | 2014 |
Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
Topics: Celecoxib; Excipients; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyethylene Glycols; Pyrazoles; Solubility; Sulfonamides; Surface Properties; Surface-Active Agents; Vitamin E; X-Ray Diffraction | 2015 |
Development and mechanistic study of a microemulsion containing vitamin E TPGS for the enhancement of oral absorption of celecoxib.
Topics: Administration, Oral; Animals; Celecoxib; Cell Death; Drug Liberation; Electric Conductivity; Electric Impedance; Emulsions; Humans; Intestinal Absorption; Intestinal Mucosa; Kinetics; Particle Size; Permeability; Rheology; Solubility; Static Electricity; Surface-Active Agents; Swine; Vitamin E | 2019 |
Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Celecoxib; Lignans; Mice; Mice, Inbred BALB C; Polyesters; Polyethylene Glycols; Vitamin E | 2020 |